




,||
Institutes for
Medical Chemistry and Biochemistry, and for
Experimental Pathology, University of Innsbruck and
* Department of Dermatology, University of Innsbruck;
Central Institute for Blood Transfusion and Immunology, University Hospital, Innsbruck; and
|| Ludwig Boltzmann Institute of AIDS-Research, Innsbrugh, Austria
Correspondence: Dr. Dietmar Fuchs, Institute of Medical Chemistry and Biochemistry, University of Innsbruck, Fritz-Pregl-Strasse 3, A-6020 Innsbruck, Austria. E-mail: Dietmar.Fuchs{at}uibk.ac.at
Increased neopterin concentrations in body fluids are found in diseases associated with activated, cell-mediated immunity including infections, autoimmune diseases, and certain malignancies. Monocytes/macrophages are known to secrete large amounts of neopterin upon stimulation with interferon-
(IFN-
). Ontogenetically, the major part of dendritic cells (DC) belongs to the myeloid lineage. Therefore, we investigated whether cultured monocyte-derived DC can elaborate neopterin. Cells were treated with cytokines in the presence or absence of monocyte-conditioned medium as a maturation stimulus. DC secreted an average 3.5 nmol/l neopterin. In response to IFN-
, cells significantly increased their output of neopterin. In distinction to monocytes/macrophages, neopterin production in DC was highly sensitive to IFN-
and IFN-ß. Further, lipopolysaccharides (LPS) enhanced neopterin synthesis, whereas tumor necrosis factor
, interleukin (IL)-1ß, IL-2, IL-10, and IL-18 were ineffective. Simultaneously, tryptophan degradation by induction of indoleamine (2,3)-dioxygenase (IDO) was tested in stimulated cells. Our results showed that IFN-
as well as LPS are inducers of IDO in DC.
Key Words: IFN-
pteridines tryptophan degradation
This article has been cited by other articles:
![]() |
A. A. Byrnes, D. M. Harris, S. F. Atabani, B. P. Sabundayo, S. J. Langan, J. B. Margolick, and C. L. Karp Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy J. Leukoc. Biol., December 1, 2008; 84(6): 1447 - 1453. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. von Bergwelt-Baildon, A. Popov, T. Saric, J. Chemnitz, S. Classen, M. S. Stoffel, F. Fiore, U. Roth, M. Beyer, S. Debey, et al. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition Blood, July 1, 2006; 108(1): 228 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sghiri, J. Feinberg, F. Thabet, K. Dellagi, J. Boukadida, A. Ben Abdelaziz, J. L. Casanova, and M. R. Barbouche Gamma Interferon Is Dispensable for Neopterin Production In Vivo Clin. Vaccine Immunol., December 1, 2005; 12(12): 1437 - 1441. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Schroecksnadel, B. Frick, and D. Fuchs Re: Plasma Folate, Vitamin B6, Vitamin B12, Homocysteine, and Risk of Breast Cancer J Natl Cancer Inst, July 16, 2003; 95(14): 1091 - 1091. [Full Text] [PDF] |
||||